vs
ARROWHEAD PHARMACEUTICALS, INC.（ARWR）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是ARROWHEAD PHARMACEUTICALS, INC.的1.7倍（$461.6M vs $264.0M），RBC Bearings INC净利率更高（14.6% vs 11.7%，领先2.9%），ARROWHEAD PHARMACEUTICALS, INC.同比增速更快（10461.3% vs 17.0%），RBC Bearings INC自由现金流更多（$99.1M vs $11.3M）
Arrowhead Pharmaceuticals是总部位于美国加利福尼亚州帕萨迪纳的上市生物制药企业，专注于通过RNA干扰（RNAi）作用机制开发创新药物，核心研发管线覆盖乙型肝炎、α-1抗胰蛋白酶缺陷相关肝病及心血管疾病的治疗领域。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
ARWR vs RBC — 直观对比
营收规模更大
RBC
是对方的1.7倍
$264.0M
营收增速更快
ARWR
高出10444.3%
17.0%
净利率更高
RBC
高出2.9%
11.7%
自由现金流更多
RBC
多$87.8M
$11.3M
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $264.0M | $461.6M |
| 净利润 | $30.8M | $67.4M |
| 毛利率 | — | 44.3% |
| 营业利润率 | 15.5% | 22.3% |
| 净利率 | 11.7% | 14.6% |
| 营收同比 | 10461.3% | 17.0% |
| 净利润同比 | 117.8% | 16.4% |
| 每股收益（稀释后） | $0.22 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARWRRBC
| Q4 25 | $264.0M | $461.6M | ||
| Q3 25 | — | $455.3M | ||
| Q2 25 | — | $436.0M | ||
| Q1 25 | — | $437.7M | ||
| Q4 24 | — | $394.4M | ||
| Q3 24 | — | $397.9M | ||
| Q2 24 | — | $406.3M | ||
| Q1 24 | — | $413.7M |
净利润ARWRRBC
| Q4 25 | $30.8M | $67.4M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $68.5M | ||
| Q1 25 | — | $72.7M | ||
| Q4 24 | — | $57.9M | ||
| Q3 24 | — | $54.2M | ||
| Q2 24 | — | $61.4M | ||
| Q1 24 | — | — |
毛利率ARWRRBC
| Q4 25 | — | 44.3% | ||
| Q3 25 | — | 44.1% | ||
| Q2 25 | — | 44.8% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | — | 44.3% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | — | 45.3% | ||
| Q1 24 | — | 43.1% |
营业利润率ARWRRBC
| Q4 25 | 15.5% | 22.3% | ||
| Q3 25 | — | 21.5% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | 23.0% | ||
| Q4 24 | — | 21.7% | ||
| Q3 24 | — | 21.6% | ||
| Q2 24 | — | 24.0% | ||
| Q1 24 | — | 22.8% |
净利率ARWRRBC
| Q4 25 | 11.7% | 14.6% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | — | 15.7% | ||
| Q1 25 | — | 16.6% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | — |
每股收益（稀释后）ARWRRBC
| Q4 25 | $0.22 | $2.13 | ||
| Q3 25 | — | $1.90 | ||
| Q2 25 | — | $2.17 | ||
| Q1 25 | — | $2.33 | ||
| Q4 24 | — | $1.82 | ||
| Q3 24 | — | $1.65 | ||
| Q2 24 | — | $1.90 | ||
| Q1 24 | — | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $715.0M | $107.6M |
| 总债务越低越好 | — | $990.2M |
| 股东权益账面价值 | $568.4M | $3.3B |
| 总资产 | $1.6B | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资ARWRRBC
| Q4 25 | $715.0M | $107.6M | ||
| Q3 25 | — | $91.2M | ||
| Q2 25 | — | $132.9M | ||
| Q1 25 | — | $36.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $76.8M | ||
| Q1 24 | — | $63.5M |
总债务ARWRRBC
| Q4 25 | — | $990.2M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $915.6M | ||
| Q1 25 | — | $920.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2B |
股东权益ARWRRBC
| Q4 25 | $568.4M | $3.3B | ||
| Q3 25 | — | $3.2B | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.8B |
总资产ARWRRBC
| Q4 25 | $1.6B | $5.1B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $4.8B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | — | $4.7B | ||
| Q3 24 | — | $4.7B | ||
| Q2 24 | — | $4.7B | ||
| Q1 24 | — | $4.7B |
负债/权益比ARWRRBC
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.5M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $11.3M | $99.1M |
| 自由现金流率自由现金流/营收 | 4.3% | 21.5% |
| 资本支出强度资本支出/营收 | 0.8% | 5.0% |
| 现金转化率经营现金流/净利润 | 0.44× | 1.81× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ARWRRBC
| Q4 25 | $13.5M | $122.1M | ||
| Q3 25 | — | $88.4M | ||
| Q2 25 | — | $120.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $84.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $97.4M | ||
| Q1 24 | — | — |
自由现金流ARWRRBC
| Q4 25 | $11.3M | $99.1M | ||
| Q3 25 | — | $71.7M | ||
| Q2 25 | — | $104.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $73.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $88.4M | ||
| Q1 24 | — | — |
自由现金流率ARWRRBC
| Q4 25 | 4.3% | 21.5% | ||
| Q3 25 | — | 15.7% | ||
| Q2 25 | — | 23.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 18.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | — |
资本支出强度ARWRRBC
| Q4 25 | 0.8% | 5.0% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | — |
现金转化率ARWRRBC
| Q4 25 | 0.44× | 1.81× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARWR
暂无分部数据
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
